MIR-376A-2-5P as a potential prognostic marker for advanced penile squamous cell carcinomas trough HPV-dependent pathways
Am J Cancer Res. 2023 Nov 15;13(11):5466-5481. eCollection 2023.ABSTRACTPenile cancer (PeCa) is a rare tumor, generally associated with socioeconomic conditions in low-income countries. Hence, a delay in diagnosis and treatment leads in more advanced tumors, to higher comorbidity, and mortality. Human papillomavirus (HPV) infection has been identified as one of the major risk factors for PeCa. In addition, viral integration sites have been related to copy number alterations, impacting miRNAs/mRNA interactions and, consequently, the molecular pathways related to them. Nonetheless, studies on differentially expressed miRNAs (miRDEs) in PeCa are still scarce, especially in PeCa associated with high-risk HPV (hrHPV). To investigate the role of these gene regulators in PeCa progression, 827 miRNAs (Nanostring Technologies™, Seattle, WA, USA) were evaluated in 22 hrHPV-associated penile squamous cell carcinomas and five non-tumor penile tissues. For functions of miRNAs/target genes and relationship with HPV we conducted an integrated analysis by Diana Tools, KEGG, HPVbase, and InterSPPI-HVPPI platforms. We found that 25 miRNAs of the most differentially expressed impact 43 top molecular pathways, of which the fatty acid biosynthesis pathway, prions, miRNAs in cancer and hippo signaling (P<1.0-325, for each) were the most statistically significant. Notably, 23 out of 25 are located at HPV integration sites (HPVis). MiR-1206, miR-376b-3p and miR-495-3p were downregulated and ass...
Source: Cell Research - Category: Cytology Authors: Jenilson M Silva Amanda J Deus Andr é A M Vale Ana Paula S Azevedo-Santos Leudivan Nogueira Ana C Laus Luciane Sussuchi Rui M Reis Alexander Birbrair Andr é S Khayat Silma Regina Pereira Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Cytology | Genetics | Genital Warts | Human Papillomavirus (HPV) | Nanotechnology | Penile Cancer | Squamous Cell Carcinoma | Statistics | Study